rs116916706

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015450.3(POT1):​c.903G>T​(p.Gln301His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00481 in 1,611,322 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0050 ( 23 hom. )

Consequence

POT1
NM_015450.3 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:13

Conservation

PhyloP100: -0.0730
Variant links:
Genes affected
POT1 (HGNC:17284): (protection of telomeres 1) This gene is a member of the telombin family and encodes a nuclear protein involved in telomere maintenance. Specifically, this protein functions as a member of a multi-protein complex that binds to the TTAGGG repeats of telomeres, regulating telomere length and protecting chromosome ends from illegitimate recombination, catastrophic chromosome instability, and abnormal chromosome segregation. Increased transcriptional expression of this gene is associated with stomach carcinogenesis and its progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039791167).
BP6
Variant 7-124851918-C-A is Benign according to our data. Variant chr7-124851918-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 475112.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=6, Benign=3, Uncertain_significance=1}. Variant chr7-124851918-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.003 (457/152258) while in subpopulation NFE AF= 0.00474 (322/67988). AF 95% confidence interval is 0.00431. There are 0 homozygotes in gnomad4. There are 207 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 23 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POT1NM_015450.3 linkc.903G>T p.Gln301His missense_variant Exon 11 of 19 ENST00000357628.8 NP_056265.2 Q9NUX5-1A0A024R739

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POT1ENST00000357628.8 linkc.903G>T p.Gln301His missense_variant Exon 11 of 19 2 NM_015450.3 ENSP00000350249.3 Q9NUX5-1

Frequencies

GnomAD3 genomes
AF:
0.00302
AC:
459
AN:
152140
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00349
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00475
Gnomad OTH
AF:
0.00383
GnomAD3 exomes
AF:
0.00275
AC:
691
AN:
250894
Hom.:
2
AF XY:
0.00302
AC XY:
409
AN XY:
135618
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.00174
Gnomad FIN exome
AF:
0.00430
Gnomad NFE exome
AF:
0.00413
Gnomad OTH exome
AF:
0.00294
GnomAD4 exome
AF:
0.00500
AC:
7294
AN:
1459064
Hom.:
23
Cov.:
29
AF XY:
0.00490
AC XY:
3555
AN XY:
726050
show subpopulations
Gnomad4 AFR exome
AF:
0.000928
Gnomad4 AMR exome
AF:
0.00123
Gnomad4 ASJ exome
AF:
0.0000766
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00208
Gnomad4 FIN exome
AF:
0.00365
Gnomad4 NFE exome
AF:
0.00586
Gnomad4 OTH exome
AF:
0.00544
GnomAD4 genome
AF:
0.00300
AC:
457
AN:
152258
Hom.:
0
Cov.:
33
AF XY:
0.00278
AC XY:
207
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.00144
Gnomad4 AMR
AF:
0.00137
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.00349
Gnomad4 NFE
AF:
0.00474
Gnomad4 OTH
AF:
0.00379
Alfa
AF:
0.00359
Hom.:
3
Bravo
AF:
0.00271
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00361
AC:
31
ExAC
AF:
0.00260
AC:
315
Asia WGS
AF:
0.00260
AC:
10
AN:
3476
EpiCase
AF:
0.00409
EpiControl
AF:
0.00374

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:13
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 09, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

POT1: BP4, BS2 -

not specified Uncertain:1Benign:3
May 05, 2021
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 08, 2021
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 19, 2018
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hereditary cancer-predisposing syndrome Benign:2
Dec 24, 2018
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Mar 01, 2021
Sema4, Sema4
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: curation

- -

POT1-related disorder Benign:1
Dec 09, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Tumor predisposition syndrome 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Tumor predisposition syndrome 3;C5830496:Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8;C5830497:Cerebroretinal microangiopathy with calcifications and cysts 3 Benign:1
Feb 17, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
11
DANN
Uncertain
0.98
DEOGEN2
Benign
0.22
T;T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.61
T;T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0040
T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Uncertain
2.6
M;.
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.14
Sift
Benign
0.14
T;T
Sift4G
Uncertain
0.057
T;T
Polyphen
0.97
D;.
Vest4
0.23
MutPred
0.25
Gain of catalytic residue at D304 (P = 0.061);.;
MVP
0.60
MPC
0.24
ClinPred
0.017
T
GERP RS
-0.75
Varity_R
0.039
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116916706; hg19: chr7-124491972; API